Stryker (NYSE:SYK) said today it extended its relationship with the PGA Tour as the “Official Joint Replacement Products” of the PGA through the 2016 season, expanding its presence at both the PGA Tour and on PGA Tour Champions.
Through the deal, Stryker said it will operate an on-site joint health site, named the “Stryker Mobility Zone,” to educate attendants on hip and knee pain as well as treatment options at 11 PGA Tour and PGA Tour Champions events.
“The ability to educate thousands of fans across the country over the last two years about joint health and treatment options has been a great experience for Stryker. To be able to make a connection between fans and the brand, engage them in conversation, and facilitate having their questions answered by local orthopaedic surgeons has truly helped Stryker to live up to our mission which is, together with our customers, we are driven to make healthcare better,” Stryker reconstructive division prez Bill Huffnagle said in prepared remarks.
Stryker said it will be introducing an interactive platform, dubbed the “Stryker Challenge,” in which participants will be able to engage in various activities and answer questions relating to joint health, mobility and golf.
Participants taking part will be entered to win a trip for 2 to TPC Sawgrass to play with former Tour winners Fred Funk and Hal Sutton.
“Since joining as an Official Marketing Partner in 2014, Stryker has been actively engaging fans at Tournaments through the popular Stryker Mobility Zone. Stryker continues to be an innovative leader in medical technology and joint replacement, an area that has directly benefited PGA Tour and PGA Tour Champions members. We are extremely pleased to continue this relationship and look forward to working with Stryker’s team to expand its presence on both the PGA Tour and PGA Tour Champions,” PGA Tour chief commercial officer Tom Wade said in prepared remarks.
The post Stryker reups PGA Tour deal appeared first on MassDevice.
from MassDevice http://ift.tt/21KZnJr
Cap comentari:
Publica un comentari a l'entrada